HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury.

Abstract
Concomitant smoke inhalation trauma in burn patients is a serious medical problem. Previous investigations in our sheep model revealed that these injuries lead to significant airway hyperemia, enhanced pulmonary fluid extravasation, and severely impaired pulmonary function. However, the pathophysiological mechanisms are still not fully understood. The lung is innervated by sensory nerves containing peptides such as substance P and calcitonin gene-related peptide. Noxious stimuli in the airways can induce a neurogenic inflammatory response, which has previously been implicated in several airway diseases. Calcitonin gene-related peptide is known to be a potent vasodilator. We hypothesized that calcitonin gene-related peptide is also a mediator of the pulmonary reaction to toxic smoke and planned experiments to evaluate its role in this model. We tested the effects of pretreatment with a specific antagonist of the major receptor for calcitonin gene-related peptide (BIBN4096BS; 32 microg/kg, followed by continuous infusion of 6.4 microg.kg(-1).h(-1)) until the animal was killed 48 h after injury in an established ovine model of burn (40% total body surface, third degree) and smoke inhalation (48 breaths, <40 degrees C) injury. In treated animals (n = 7), the injury-related increases in tracheal blood flow and lung lymph flow were significantly attenuated compared with untreated controls (n = 5). Furthermore, the treatment significantly attenuated abnormalities in respiratory gas exchange. The data suggest that calcitonin gene-related peptide contributes to early airway hyperemia, transvascular fluid flux, and respiratory malfunction following ovine burn and smoke inhalation injury. Future studies will be needed to clarify the potential therapeutic benefit for patients with this injury.
AuthorsMatthias Lange, Perenlei Enkhbaatar, Daniel L Traber, Robert A Cox, Sam Jacob, Babu P Mathew, Atsumori Hamahata, Lillian D Traber, David N Herndon, Hal K Hawkins
JournalJournal of applied physiology (Bethesda, Md. : 1985) (J Appl Physiol (1985)) Vol. 107 Issue 1 Pg. 176-84 (Jul 2009) ISSN: 8750-7587 [Print] United States
PMID19407258 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Piperazines
  • Quinazolines
  • Calcitonin Gene-Related Peptide
  • olcegepant
Topics
  • Acute Lung Injury (metabolism, physiopathology, prevention & control)
  • Animals
  • Calcitonin Gene-Related Peptide (analogs & derivatives, antagonists & inhibitors, metabolism)
  • Disease Models, Animal
  • Female
  • Infusions, Intravenous
  • Lung (drug effects, pathology, physiopathology)
  • Lymph (physiology)
  • Microcirculation (drug effects, physiology)
  • Piperazines (administration & dosage, pharmacology)
  • Pulmonary Edema (pathology, physiopathology, prevention & control)
  • Pulmonary Gas Exchange (drug effects)
  • Quinazolines (administration & dosage, pharmacology)
  • Sheep
  • Smoke Inhalation Injury (metabolism, physiopathology, prevention & control)
  • Trachea (blood supply)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: